- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.00 Å
- Oligo State
- homo-trimer
- Ligands
- 9 x ACT: ACETATE ION(Non-functional Binders)
- 6 x NA: SODIUM ION(Non-functional Binders)
NA.3: 5 residues within 4Å:- Ligands: ACT.2, ACT.8, NA.9, ACT.14, NA.15
No protein-ligand interaction detected (PLIP)NA.4: 2 residues within 4Å:- Ligands: ACT.2, ACT.5
No protein-ligand interaction detected (PLIP)NA.9: 5 residues within 4Å:- Ligands: ACT.2, NA.3, ACT.8, ACT.14, NA.15
No protein-ligand interaction detected (PLIP)NA.10: 2 residues within 4Å:- Ligands: ACT.8, ACT.11
No protein-ligand interaction detected (PLIP)NA.15: 5 residues within 4Å:- Ligands: ACT.2, NA.3, ACT.8, NA.9, ACT.14
No protein-ligand interaction detected (PLIP)NA.16: 2 residues within 4Å:- Ligands: ACT.14, ACT.17
No protein-ligand interaction detected (PLIP)- 3 x 3OX: (2S,4S)-4-HYDROXY-2-(1-METHYLETHYL)-4-[(4R,13S)-18-[METHYL(METHYLSULFONYL)AMINO]-2,15-DIOXO-4-PHENYL-11-OXA-3,14-DIAZATRICYCLO[14.3.1.1~5,9~]HENICOSA-1(20),5(21),6,8,16,18-HEXAEN-13-YL]-N-(2-METHYLPROPYL)BUTANAMIDE(Non-covalent)
3OX.6: 24 residues within 4Å:- Chain A: Q.19, D.38, G.40, S.41, R.82, Y.83, S.84, T.85, P.118, F.119, L.121, F.124, Q.135, I.137, D.226, G.228, A.229, S.230, Y.231, I.232, S.233, H.301, M.303
- Ligands: ACT.1
15 PLIP interactions:15 interactions with chain A- Hydrophobic interactions: A:Q.19, A:T.85, A:P.118, A:F.119, A:L.121, A:Q.135, A:I.137
- Hydrogen bonds: A:D.38, A:G.40, A:G.40, A:S.84, A:T.85, A:G.228, A:S.230
- pi-Stacking: A:F.124
3OX.12: 24 residues within 4Å:- Chain B: Q.19, D.38, G.40, S.41, R.82, Y.83, S.84, T.85, P.118, F.119, L.121, F.124, Q.135, I.137, D.226, G.228, A.229, S.230, Y.231, I.232, S.233, H.301, M.303
- Ligands: ACT.7
16 PLIP interactions:16 interactions with chain B- Hydrophobic interactions: B:Q.19, B:T.85, B:P.118, B:F.119, B:L.121, B:Q.135, B:I.137
- Hydrogen bonds: B:D.38, B:G.40, B:G.40, B:S.84, B:T.85, B:G.228, B:S.230, B:H.301
- pi-Stacking: B:F.124
3OX.18: 24 residues within 4Å:- Chain C: Q.19, D.38, G.40, S.41, R.82, Y.83, S.84, T.85, P.118, F.119, L.121, F.124, Q.135, I.137, D.226, G.228, A.229, S.230, Y.231, I.232, S.233, H.301, M.303
- Ligands: ACT.13
16 PLIP interactions:16 interactions with chain C- Hydrophobic interactions: C:Q.19, C:T.85, C:P.118, C:F.119, C:L.121, C:Q.135, C:I.137
- Hydrogen bonds: C:D.38, C:G.40, C:G.40, C:S.84, C:T.85, C:G.228, C:S.230, C:H.301
- pi-Stacking: C:F.124
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Sund, C. et al., Design and synthesis of potent macrocyclic renin inhibitors. Bioorg.Med.Chem.Lett. (2011)
- Release Date
- 2010-12-15
- Peptides
- Renin: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.00 Å
- Oligo State
- homo-trimer
- Ligands
- 9 x ACT: ACETATE ION(Non-functional Binders)
- 6 x NA: SODIUM ION(Non-functional Binders)
- 3 x 3OX: (2S,4S)-4-HYDROXY-2-(1-METHYLETHYL)-4-[(4R,13S)-18-[METHYL(METHYLSULFONYL)AMINO]-2,15-DIOXO-4-PHENYL-11-OXA-3,14-DIAZATRICYCLO[14.3.1.1~5,9~]HENICOSA-1(20),5(21),6,8,16,18-HEXAEN-13-YL]-N-(2-METHYLPROPYL)BUTANAMIDE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Sund, C. et al., Design and synthesis of potent macrocyclic renin inhibitors. Bioorg.Med.Chem.Lett. (2011)
- Release Date
- 2010-12-15
- Peptides
- Renin: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
A